Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | APLNR | P35414 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | KDM1A | O60341 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6431460 | 0.80 | SIGMAR1 (0.37) | ALDH1A1SIGMAR1KDM1AKDM4EMAOB | |
| SCHEMBL3899507 | 0.80 | SIGMAR1 (0.37) | ALDH1A1SIGMAR1KDM1AKDM4EMAOB | |
| SCHEMBL2197649 | 0.79 | SLC18A3 (0.49) | ALDH1A1SIGMAR1KDM4E | |
| SCHEMBL29615873 | 0.79 | SLC18A3 (0.49) | ALDH1A1SIGMAR1KDM4E | |
| SCHEMBL490929 | 0.79 | SLC18A3 (0.49) | ALDH1A1SIGMAR1KDM4E | |
| SCHEMBL2936927 | 0.79 | SLC18A3 (0.49) | ALDH1A1SIGMAR1KDM4E | |
| Bromide SCHEMBL19897108 | 0.78 | SLC18A3 (0.47) | ALDH1A1SIGMAR1KDM4E | |
| Bromide SCHEMBL16799712 | 0.78 | SLC18A3 (0.47) | ALDH1A1SIGMAR1KDM4E | |
| Bromide SCHEMBL19897327 | 0.78 | SLC18A3 (0.47) | ALDH1A1SIGMAR1KDM4E | |
| SCHEMBL22090400 | 0.77 | KCNA5 (0.41) | KCNA5ALDH1A1SIGMAR1APLNREPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050288525-A1 | Reagents for asymmetric allylation, aldol, and tandem aldol and allylation reactions | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-12-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050288525-A1 | Reagents for asymmetric allylation, aldol, and tandem aldol and allylation reactions | AKR1C3, AKR1B10, CBR3 | KCNA5 2846/4885ALDH1A1 27/4885SIGMAR1 451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.